Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 531 for Thrombocytopenia in Non-Hodgkin's Lymphoma Receiving Chemotherapy
NCT00299182Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2006
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2006; status: completed.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00299182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299182.